| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/19/2012 | US20120095439 Implantable therapeutic device |
| 04/19/2012 | US20120095108 Composition containing microbial zeaxanthin and preparation thereof |
| 04/19/2012 | US20120095102 Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof |
| 04/19/2012 | US20120095101 Aqueous intraocular penetration-promoting eye drop |
| 04/19/2012 | US20120095097 Ophthalmic composition |
| 04/19/2012 | US20120095090 Novel composition and method for stabilizing the same |
| 04/19/2012 | US20120095062 Tricyclic compounds, compositions, and methods |
| 04/19/2012 | US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 04/19/2012 | US20120095050 Stabilized and preserved ketotifen ophthalmic compositions |
| 04/19/2012 | US20120095049 Nociceptin analogs |
| 04/19/2012 | US20120095046 Amido-Isothiazole Compounds and Their Use as Inhibitors of 11Beta-HSD1 for the Treatment of Metabolic Syndrome and Related Disorders |
| 04/19/2012 | US20120095040 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof |
| 04/19/2012 | US20120095033 Selective Glycosidase Inhibitors and Uses Thereof |
| 04/19/2012 | US20120095025 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS |
| 04/19/2012 | US20120095024 Toluidine sulfonamides and their use |
| 04/19/2012 | US20120095005 Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors |
| 04/19/2012 | US20120095004 Sphingosine Kinase Inhibitors |
| 04/19/2012 | US20120094978 Ocular Allergy Treatments |
| 04/19/2012 | US20120094972 Heterocyclic compounds and their uses |
| 04/19/2012 | US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE |
| 04/19/2012 | US20120094966 Organic compounds |
| 04/19/2012 | US20120094962 Pharmaceutical composition for use in medical and veterinary ophthalmology |
| 04/19/2012 | US20120094957 Inhibitors of fatty acid amide hydrolase |
| 04/19/2012 | US20120094944 Novel imidazopyridine compound |
| 04/19/2012 | US20120094918 Method of using diketopiperazines and composition containing them |
| 04/19/2012 | US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 04/19/2012 | US20120094894 Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics |
| 04/19/2012 | US20120094893 Method of using diketopiperazines and composition containing them |
| 04/19/2012 | US20120093931 Inhibition of Neovascularization by Cerium Oxide Nanoparticles |
| 04/19/2012 | US20120093894 Stable cyclosporine containing ophthalmic emulsion for treating dry eyes |
| 04/19/2012 | US20120093883 Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions |
| 04/19/2012 | US20120093876 Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions |
| 04/19/2012 | US20120093857 Vaccination and Immunotherapy as New Therapeutic Modalities in the Treatment of Glaucoma |
| 04/19/2012 | US20120093829 New methods for treatment of inflammatory diseases |
| 04/19/2012 | US20120093796 Novel use of ec-sod and method for preparing thereof |
| 04/19/2012 | US20120093772 Vectors for delivery of light sensitive proteins and methods of use |
| 04/19/2012 | US20120093770 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 04/19/2012 | US20120093768 Anti-connexin compounds targeted to connexins and methods of use thereof |
| 04/19/2012 | CA2814628A1 Acylbenzene derivative |
| 04/19/2012 | CA2807036A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases |
| 04/18/2012 | EP2441453A1 Pharmaceutical composition for use in medical and veterinary ophthalmology |
| 04/18/2012 | EP2440537A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| 04/18/2012 | EP2440226A1 Vaccine therapy for choroidal neovascularization |
| 04/18/2012 | EP2440223A1 Compositions and methods for increasing lifespan and health span |
| 04/18/2012 | EP2440185A1 Topical drug delivery systems for ophthalmic use |
| 04/18/2012 | EP2440054A1 Pyridil-triazine inhibitors of hedgehog signaling |
| 04/18/2012 | EP1499358B1 Ph-sensitive polymer |
| 04/18/2012 | EP1409467B1 A n-acylsphingosine glucosyltransferase inhibitor |
| 04/18/2012 | CN102421425A Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 04/18/2012 | CN102416178A Water-soluble non-aggregated alkoxy-substituted phthalocyanine-silica nanometer particle |
| 04/18/2012 | CN102416126A 一种治疗白塞氏病的中药组合剂及其制备方法 Behcet's disease is a combination of traditional Chinese medicine and its preparation method of treatment |
| 04/18/2012 | CN102416106A Chinese medicinal composition for treating middle-aged and senile eye disease and preparation method thereof |
| 04/18/2012 | CN101829048B 一种滴眼液及其制备方法 One kind of eye drops and its preparation method |
| 04/18/2012 | CN101601827B 一种预防和/或治疗干燥综合症、延缓衰老的保健食品或中药制剂及其制备方法 A prevention and / or treatment of Sjogren's syndrome, delayed health food or medicine and its preparation method of aging |
| 04/18/2012 | CN101432000B 用于变应性眼病或变应性鼻病的包含三环性三唑并苯并氮杂*衍生物的预防剂或治疗剂 * Azepine derivative preventive or therapeutic agent for allergic ophthalmic diseases or allergic nasal diseases, comprising a tricyclic triazolo benzo |
| 04/17/2012 | US8158669 Method for treating neovascularization |
| 04/17/2012 | US8158578 Methods for treating neurological deficits |
| 04/17/2012 | CA2676082C Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract |
| 04/17/2012 | CA2660151C Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof |
| 04/17/2012 | CA2363958C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 04/12/2012 | WO2012047893A2 Use of rifazil and analogues thereof to treat ocular disorders |
| 04/12/2012 | WO2012047706A2 Methods for promotiing reinnervation of auditory hair cells |
| 04/12/2012 | WO2012047587A2 Mdm2 inhibitors for treatment of ocular conditions |
| 04/12/2012 | WO2012046793A1 Novel jak3 inhibitor containing, as active ingredient, thiophene derivative having ureido group and aminocarbonyl group as substituents |
| 04/12/2012 | WO2012006083A3 Targeted receptor-mediated sirna |
| 04/12/2012 | WO2011163452A9 Treating surface of the eye disorders |
| 04/12/2012 | WO2011159881A3 Il-10 and methods of treating ocular and other diseases |
| 04/12/2012 | US20120088844 Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains |
| 04/12/2012 | US20120088843 Polymerizable chain-extended polysiloxanes with pendant hydrophilic groups |
| 04/12/2012 | US20120088839 Composition for regulating cellular senescence comprising [n-2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide |
| 04/12/2012 | US20120088825 Compounds with activity at estrogen receptors |
| 04/12/2012 | US20120088800 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS |
| 04/12/2012 | US20120088784 Substituted Aromatic Compounds and Pharmaceutical Uses thereof |
| 04/12/2012 | US20120088783 Chroman derivatives |
| 04/12/2012 | US20120088778 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/12/2012 | US20120088776 Treatment of mammalian disorders mediated by alpha-anhydrase isoforms |
| 04/12/2012 | US20120088769 Salts of arylsulfonamide ccr3 antagonists |
| 04/12/2012 | US20120088768 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
| 04/12/2012 | US20120088760 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient |
| 04/12/2012 | US20120088751 Pharmaceutical compounds |
| 04/12/2012 | US20120088747 Sulfonamide containing compounds and uses thereof |
| 04/12/2012 | US20120088741 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase |
| 04/12/2012 | US20120088739 Method for treating meibomian gland disease |
| 04/12/2012 | US20120088734 Cyclosporin Analogs |
| 04/12/2012 | US20120088732 Therapeutic composition comprising a botulinum neurotoxin |
| 04/12/2012 | US20120087971 Contact drug delivery system |
| 04/12/2012 | US20120087929 VEGF Antagonist Formulations for Intravitreal Administration |
| 04/12/2012 | US20120087928 Therapeutics for age-related macular degeneration |
| 04/12/2012 | US20120087925 Method for the treatment of inflammatory disorders |
| 04/12/2012 | US20120087912 Treatment methods using dkk-1 antibodies |
| 04/12/2012 | US20120087864 Method for diagnosing and/or evaluating retinal disease |
| 04/12/2012 | DE102010042360A1 Nasal spray bottle, useful for dilution of drug to be administered, and for preventing or treating rhinitis medicamentosa, preferably withdrawal rhinitis medicamentosa, comprises a spray nozzle and a two chamber system |
| 04/12/2012 | CA2813734A1 Use of rifalazil and analogues thereof to treat ocular disorders |
| 04/11/2012 | EP2439202A1 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 04/11/2012 | EP2437745A1 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms |
| 04/11/2012 | EP2437743A1 Ophthalmic formulations of fluticasone and methods of use |
| 04/11/2012 | EP2437728A2 Therapeutic ophthalmic emulsions |
| 04/11/2012 | EP2437719A1 Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid |
| 04/11/2012 | EP1296923B3 Aspirin-triggered lipid mediators |
| 04/11/2012 | EP1261590B1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |